Fingerprint
Dive into the research topics of 'Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
R. Advani, G. Visani, D. Milligan, H. Saba, M. Tallman, J. M. Rowe, P. H. Wiernik, J. Ramek, K. Dugan, B. Lum, J. Villena, E. Davis, E. Paietta, M. Litchman, A. Covelli, B. Sikic, P. Greenberg
Research output: Contribution to journal › Article › peer-review